非小細胞肺癌：企業と競争環境...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
2.3 Upcoming Related Reports 12
3 Market Outlook 13
3.1 Global Markets 13
3.1.1 Forecast 13
3.1.2 Drivers and Barriers – Global Issues 17
4 Current and Future Players 21
4.1 Overview 21
4.2 Trends in Corporate Strategy 24
4.3 Company Profiles 25
4.3.1 Roche/Genentech 25
4.3.2 Pfizer 28
4.3.3 Bristol-Myers Squibb 30
4.3.4 Eli Lilly 34
4.3.5 Boehringer Ingelheim 37
4.3.6 Novartis 39
5 Appendix 41
5.1 Bibliography 41
5.2 Abbreviations 49
5.3 Methodology 51
5.4 Forecasting Methodology 51
5.4.1 Number of NSCLC Patients Currently Seeking Treatment 51
5.4.2 Percent Drug-treated Patients 52
5.4.3 Drugs Included in Each Therapeutic Class 52
5.4.4 Launch and Patent Expiry Dates 53
5.4.5 General Pricing Assumptions 55
5.4.6 Individual Drug Assumptions 57
5.5 Physicians and Specialists Included in This Study 68
5.6 Survey of Prescribing Physicians 70
5.7 About the Authors 71
5.7.1 Authors 71
5.7.2 Global Head of Healthcare 72
5.8 About GlobalData 73
5.9 Disclaimer 73